Fresh Recalls

FDAClass II · Drug · Recall D-0768-2026 · Recalled August 19, 2026

CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION recall — Heritage Pharmaceuticals Inc

Agency report date: August 19, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION
Company / brand
Heritage Pharmaceuticals
Lot / serial / date codes
Lot #: 2411550, Exp. 2026/NOV.
Distribution
Nationwide within the U.S
Agency product description and boundaries

CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION

3. Open the official notice or contact

Official recall ID
D-0768-2026
Brand
Heritage Pharmaceuticals
Classification
Class II
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
East Brunswick, NJ, United States
Firm address
1 Tower Center Blvd Ste 1700, 08816-1145

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 2411550, Exp. 2026/NOV.
Distribution
Nationwide within the U.S
Firm notified the public via
Letter
FDA event ID
99526
Recall initiated
July 30, 2026
FDA classified
August 14, 2026
FDA report date
August 19, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page